Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 50Carcinoma, Non-Small-Cell Lung 36Ovarian Neoplasms 35Stomach Neoplasms 32Esophageal Neoplasms 29Uterine Cervical Neoplasms 21Esophageal Squamous Cell Carcinoma 19Fallopian Tube Neoplasms 16Lung Neoplasms 13Carcinoma, Ovarian Epithelial 13Neoplasms 9Head and Neck Neoplasms 9Carcinoma, Squamous Cell 9Triple Negative Breast Neoplasms 8Recurrence 8Neoplasm Metastasis 6Endometrial Neoplasms 6Advanced Gastric Cancer 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Nasopharyngeal Neoplasms 5Hypopharyngeal Neoplasms 4Oropharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Mouth Neoplasms 3Melanoma 3Laryngeal Neoplasms 3Carcinoma 3Anus Neoplasms 3Adenocarcinoma Of Esophagus 3

Interventions

Dexamethasone 11Aprepitant 8Olanzapine 5ramosetron 4Palonosetron 4fosaprepitant 3Ondansetron 3Granisetron 3netupitant, palosentron drug combination 2Tropisetron 2Calcium Dobesilate 2netupitant 1lerisetron 1dexamethasone 21-phosphate 1Transcranial Direct Current Stimulation 1Tablets 1Serotonin 5-HT3 Receptor Antagonists 1Radiotherapy 1Paclitaxel 1Music Therapy 1Metoclopramide 1Megestrol Acetate 1Megestrol 1Gelatin 1Dronabinol 1Dosage Forms 1Carboplatin 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Vomiting × Paclitaxel × Clear all
NCT02290470 2014-11-14

Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
81 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡